Company · Healthtech & Bio

Avamed Synergy

avamedsynergy.es ↗ ·Alicante ·Seed

Avamed Synergy is a Spanish deep-tech medtech company building digital surgery and predictive oncology software, led by its Fluxus platform, which uses AI, big data and predictive modelling on medical imaging to forecast individual tumour evolution and simulate complex surgical procedures. Founded in 2012 and based at the Distrito Digital hub in Alicante (with Murcian origins), it holds Spain's Innovative SME seal and runs clinical research collaborations with IMIB Murcia, IBIMA Málaga, SACYL Innova, ISABIAL and INCLIVA, having supported 80+ complex surgical cases. It closed a first ~€800K round in early 2024 (including ENISA) and opened a ~€5M round in 2025 ahead of CE marking and market entry targeted for 2026.

Founded
2012
Founders
1
News
9
Rounds
2
Investors
1
SectorsHealthtech, Medtech, Digital Surgery, Oncology, AI & Data, Deeptech, Medical Imaging Start-up MapHealthtech & Bio › Clinical software & health data

Profile updated 6 Sep 2026

Founders

Lucas Antonio Diez Martínez
CEO and Founder

Global models

No comparables on record yet.

Investors 1

Investor Spain

Funding rounds 2

Seed
Spanish press reported on 10 April 2025 that Avamed Synergy had 'recently closed' an internal expansion round (ronda de ampliacion interna) …
2025-04-10
Seed · €800K
Alicante-based deeptech Avamed Synergy closed the first phase of its first investment round at €800,000 to advance Fluxus, an AI-based preci…
2024-01-08

News & media 9

Start typing to search across everything.
↑↓ navigate↵ openesc close